Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Givner

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Clinical Pediatrics|September 1, 1983
Myocarditis as a complication of infantile Chlamydia trachomatis pneumonitisR E Ringel, L B Givner, J I Brenner, et al.
Pediatrics in Review|April 3, 2009
Index of suspicionAmir Mian, David Becton, Douglas P Blackall, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Safety and immunogenicity of palivizumab (Synagis) administered for two seasonsDonald Null, Bernard Pollara, Penelope H Dennehy, et al.
Infection Control and Hospital Epidemiology|December 8, 2018
A regional collaboration between competing healthcare systems to establish influenza season parametersDavid H Priest, Susan L DeCamp-Freeze, Cynthia B Snider, et al.
The Pediatric Infectious Disease Journal|May 29, 2007
Recurrent systemic pneumococcal disease in childrenEdward O Mason, Ellen R Wald, Tina Q Tan, et al.
Pediatrics|December 2, 1998
Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG)J S Bradley, S L Kaplan, T Q Tan, et al.
Pediatrics|February 24, 2010
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in childrenSheldon L Kaplan, William J Barson, Philana L Lin, et al.
Pediatrics|August 18, 2019
Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017Sheldon L Kaplan, William J Barson, Philana Ling Lin, et al.
The Pediatric Infectious Disease Journal|April 6, 2013
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccineSheldon L Kaplan, William J Barson, Philana Ling Lin, et al.
The Pediatric Infectious Disease Journal|March 11, 1998
Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study GroupK N Subramanian, L E Weisman, T Rhodes, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Clinical Pediatrics|September 1, 1983
Myocarditis as a complication of infantile Chlamydia trachomatis pneumonitisR E Ringel, L B Givner, J I Brenner, et al.
Pediatrics in Review|April 3, 2009
Index of suspicionAmir Mian, David Becton, Douglas P Blackall, et al.
The Pediatric Infectious Disease Journal|November 12, 2005
Safety and immunogenicity of palivizumab (Synagis) administered for two seasonsDonald Null, Bernard Pollara, Penelope H Dennehy, et al.
Infection Control and Hospital Epidemiology|December 8, 2018
A regional collaboration between competing healthcare systems to establish influenza season parametersDavid H Priest, Susan L DeCamp-Freeze, Cynthia B Snider, et al.
The Pediatric Infectious Disease Journal|May 29, 2007
Recurrent systemic pneumococcal disease in childrenEdward O Mason, Ellen R Wald, Tina Q Tan, et al.
Pediatrics|December 2, 1998
Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG)J S Bradley, S L Kaplan, T Q Tan, et al.
Pediatrics|February 24, 2010
Serotype 19A Is the most common serotype causing invasive pneumococcal infections in childrenSheldon L Kaplan, William J Barson, Philana L Lin, et al.
Pediatrics|August 18, 2019
Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017Sheldon L Kaplan, William J Barson, Philana Ling Lin, et al.
The Pediatric Infectious Disease Journal|April 6, 2013
Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccineSheldon L Kaplan, William J Barson, Philana Ling Lin, et al.
The Pediatric Infectious Disease Journal|March 11, 1998
Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study GroupK N Subramanian, L E Weisman, T Rhodes, et al.
Pageof 9